Subepidermal autoimmune bullous skin diseases associated with B-cell lymphoproliferative disorders

Medicine

Volumn 78, Issue 4, 1999, Pages 228-235

  Aractingi, Sélim ^a   Bachmeyer, Claude ^a   Prost, Catherine ^b   Caux, Fréderic ^b   Flageul, Béatrice ^b   Fermand, Jean Paul ^b  

^a HÔPITAL TENON   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; LYMPHOPROLIFERATIVE DISEASE; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY;

AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; LYMPHOPROLIFERATIVE DISORDERS; MALE; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN DISEASES, VESICULOBULLOUS;

EID: 0032854660     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199907000-00003     Document Type: Article

References (31)

1. Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, Izumi H, Ratrie H III, Mutasim D, Ariss-Abdo L, Labib RS. Paraneoplastic pemphigus: An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 323: 1729-35, 1990.
2. Baler GR. Epidermolysis bullosa acquisita associated with lymphoma. J Am Acad Dermatol 17: 856-59, 1987.
3. Bastuji-Garin S, Souissi R, Blum L, Turki H, Nouira R, Jomaa B, Zahaf A, Ben Osman A, Mokhtar I, Fazza B, Revuz J, Roujeau JC, Kamoun MR. Comparative epidemiology of pemphigus in Tunisia and France: Unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol 104: 302-5, 1995.
4. Bernard P, Prost C, Lecerf V, Intrator L, Combemale P, Bedane C, Roujeau JC, Revuz J, Bonnetblanc JM, Dubertret L. Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. J Invest Dermatol 94: 630-35, 1990.
5. Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux JP, Lorette G, Bonnetblanc JM, Prost C. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Arch Dermatol 131: 48-52, 1995.
6. Briggaman RA, Woodley DT. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid). J Invest Dermatol 85: 79s-84s, 1985.
7. Briggaman RA, Gammon RW, Woodley DT. Epidermolysis bullosa acquisita. In: Wojnarowska F, Briggaman RA, eds. Management of blistering disease. London: Chapman Hall Medical, pp 127-38, 1990.
8. Bureau Y, Barriere H, Litoux P, Bureau B. Manifestations cutanees vesiculo-bulleuses specifiques au cours des leucoses lymphoides. Ann Dermatol Syph 98: 261-64, 1971.
9. Bystryn JC, Hodak E, Gao SQ, Chuba JV, Amorosi EL. A paraneoplastic mixed bullous skin disease associated with anti-skin antibodies and a B-cell lymphoma. Arch Dermatol 129: 870-75, 1993.
10. Cobb MW, Domloge-Hultsch N, Frame JN, Yancey KB. Waldenstrom macroglobulinemia with an IgM-k antiepidermal basement membrane zone antibody. Arch Dermatol 128: 372-76, 1992.
11. Cuni LJ, Grunwald H, Rosner F. Bullous pemphigoid in chronic lymphoid leukemia with the demonstration of antibasement membrane antibodies. Am J Med 57: 987-92, 1974.
12. Dimopoulos MN, Alexanian R. Waldenstrom's macroglobulinemia. Blood 83: 1452-59, 1994.
13. Duhrsen U, Augener W, Zwingers T, Brittinger G. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: Analysis of 637 cases and comparison with myeloproliferative diseases. Br J Haematol 67: 235-39, 1987.
14. Farhangi M, Merlini G. The clinical implications of monoclonal immunoglobulins. Semin Oncol 13: 366-79, 1986.
15. Compel A, Bletry O, de Prost Y, Wechsler J, Wechsler B, Lebon P, Godeau P. Bullous dermatosis associated with dysglobulinemia (two cases). Relationships with epidermolysis bullosa acquisita. Biomed Pharmacother 36: 199-203, 1982.
16. Goodnough LT, Muir WA. Bullous pemphigoid as a manifestation of chronic lymphocytic leukemia. Arch Intern Med 140: 1526-27, 1980.
17. Hamblin TD, Oscier DG, Young BJ. Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol 39: 713-16, 1986.
18. Kipps TJ. Chronic lymphocytic leukemia. Curr Opin Haematol 4: 268-76, 1997.
19. Kipps TJ, Carson DA. Autoantibodies in chronic lymphocytic leukaemia and related systemic autoimmune diseases. Blood 81:2475-87, 1993.
20. Mariette X, Tsapis A, Brouet JC. Nucleotidic sequence analysis of the variable domains of four human monoclonal IgM with an autoantibody activity to myelin activated glycoprotein. Eur J Immunol 23: 846-51, 1993.
21. Myint H, Copplestone JA, Orchard J, Craig V, Curtis D, Prentice AG, Hamon MD, Oscier DG, Hamblin TJ. Fludarabine-related autoimmune haematological anaemia in patients with chronic lymphocytic leukaemia. Br J Haematol 91: 341-44, 1995.
22. Nousari HC, Anhalt GJ. Bullous skin diseases. Curr Opin Immunol 7: 844-52, 1995.
23. O'Brien S, del Giglio A, Keating M. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 85: 307-18, 1995.
24. Pech JH, Moreau-Cabarrot A, Oksman F, Bedane C, Bernard C, Bazex J. Macroglobulinemie de Waldenstrom avec activite anti membrane basale de l'immunoglobuline monoclonale. Ann Dermatol Venereol 124: 325-28, 1997.
25. Pleyer U, Bruckner-Tuedreman L, Friedmann A, Hartmann L, Simon J, Sterry W. The immunology of bullous oculo-muco-cutaneous disorders. Immunol Today 17: 111-13, 1996.
26. Rettig MB, Vescio RA, Cao J, Wu CH, Lee JC, Han E, DerDanielan M, Newman R, Hong C, Lichtenstein AK, Berenson JR. VH gene usage in multiple myeloma: Complete absence of the VH 4.21 (VH4-34) gene. Blood 87: 2846-52, 1996.
27. Sachs O. Veber pemphygoide Hauteruption in einem Falle von lymphatischer Leukaemie. Wien Klin Wochenschr 34:317-19, 1921.
28. Steck AJ, Murray N, Dellagi K, Brouet JC, Seligmann M. Peripheral neuropathy associated with monoclonal IgM autoantibody. Ann Neurol 22: 764-67, 1987.
29. West NY, Fitzpatrick JE, David-Bajar KM, Bennion SD. Waldenstrom macroglobulinemia-induced bullous dermatosis. Arch Dermatol 134: 1127-31, 1998.
30. Whittaker SJ, Bhogal BS, Black MM. Acquired immunobullous disease: A cutaneous manifestation of IgM macroglobulinaemia. Br J Dermatol 135: 283-86, 1996.
31. Zillikens D, Wever S, Roth A, Weidenthaler Barth B, Hashimoto T, Brocker EB. Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 131: 955-58, 1995.